Wegovy Wegovy, with semaglutide as its active ingredient, was developed and approved for weight loss following Ozempics off-label use for this purpose
Tell us if you have or think you might have sleep apnea
That said, assessing the research used in gaining FDA approval can help you understand how much some people have lost on the drug, so you can set your expectations accordingly
Patients with a history of pancreatitis, medullary thyroid cancer, significant gastrointestinal issues, or a known allergy to GLP-1 receptor agonists should consult our providers before considering this treatment
These ranges create a deficit of approximately 500 to 750 calories below total daily energy expenditure, which supports a safe loss rate of one to two pounds per week
The tirzepatide vs semaglutide dosage comparison shows tirzepatide outperforms semaglutide by 5-7 percentage points in weight loss